The Atomic Bombings of Hiroshima and Nagasaki: A Summary of the Human Consequences, 1945-2018, and Lessons for Homo sapiens to End the Nuclear Weapon Age
Clicks: 276
ID: 108854
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Star Article
81.3
/100
275 views
221 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Seventy-four years have passed since the atomic bombings of Hiroshima and Nagasaki. Approximately 210,000 victims died, and another 210,000 people survived. The damage to their health has continued, consisting of three phases of late effects: the appearance of leukemia, the first malignant disease, in 1949; an intermediate phase entailing the development of many types of cancer; and a final phase of lifelong cancers for hibakusha who experienced the bombing as a child, as well as a second wave of leukemia for elderly hibakusha and psychological damage such as depression and post-traumatic stress disorder. Thus, the human consequences of the atomic bombings have not ceased; many people are still dying of radiation-induced malignant diseases. Therefore, it is too early to finalize the total death toll. Hibakusha have faced a never-ending struggle to regenerate their lives and families under the fear of disease. As the only group of Homo sapiens experiencing real nuclear attacks, hibakusha have continued to engage in a lifelong movement to eliminate nuclear weapons. Political leaders, especially of nuclear-weapon states, must learn the wisdom of the hibakusha to save Homo sapiens from possible global extinction by nuclear war.
| Reference Key |
tomonaga2019thejournal
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Tomonaga, Masao; |
| Journal | journal for peace and nuclear disarmament |
| Year | 2019 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.